SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

Parexel International Corp. (PRXL)

PRXL RSS Feed
Add PRXL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 8/8/2016 12:57:11 PM - Followers: 2 - Board type: Free - Posts Today: 0
Parexel International Corporation, a biopharmaceutical services company, provides clinical research, medical marketing, consulting, and informatics and advanced technology products and services to pharmaceutical, biotechnology, and medical device industries worldwide. The company operates through three segments: Clinical Research Services, PAREXEL Consulting and Medical Marketing, and Perceptive. The Clinical Research Services segment offers clinical trials management and biostatistics, data management, and clinical pharmacology, as well as related medical advisory and investigator site services. It provides these services in cardiology, oncology, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology, obstetrics/gynecology, orthopedics, pediatrics, psychiatry, and transplantation areas. The PAREXEL Consulting and Medical Marketing segment offers drug development, regulatory, manufacturing compliance, business process consulting, staffing solutions, and marketing expertise consultation to the pharmaceutical, biopharmaceutical, and medical device industries in the United States, Europe, and Asia. The Perceptive segment offers a portfolio of products and services that include medical imaging services, interactive voice response systems, clinical trials management systems, Web-based portals, systems integration, and patient diary applications. PAREXEL was founded by Josef H. von Rickenbach in 1983. The company is headquartered in Waltham, Massachusetts.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PRXL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PRXL News: Initial Statement of Beneficial Ownership (3) 09/27/2016 12:17:50 PM
PRXL News: PAREXEL Announces Execution of Definitive Agreement to Acquire ExecuPharm 09/26/2016 09:00:00 AM
PRXL News: Current Report Filing (8-k) 09/20/2016 03:28:26 PM
PRXL News: Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting 09/19/2016 09:00:00 AM
PRXL News: Statement of Changes in Beneficial Ownership (4) 09/16/2016 04:17:32 PM
PostSubject
#10   Hi June: shub 08/08/16 12:57:11 PM
#9   I have also have owned this ticker for junewong 08/07/16 05:15:03 PM
#8   This board is obviously moribund; but iv'e held shub 07/22/16 04:19:15 PM
#7   Well on the way... junewong 08/17/15 03:11:06 PM
#6   ~ $PRXL ~ Earnings posted, pending or coming Penny Roger$ 02/02/12 12:30:53 AM
#5   PRXL $20 PAREXEL has been mlkrborn 11/15/11 02:49:39 PM
#4   http://events.jspargo.com/asco10/public/Booth.aspx?IndexInList=1&FromPage=Exhibi surf1944 04/14/10 11:23:45 AM
#3   6:02AM PAREXEL announces that it has completed a surf1944 03/17/10 10:20:26 AM
#2   That was almost to the moon...very good! MrSparex 02/03/07 10:35:45 PM
#1   To da MOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOON!!!!!!!!!!!!!!!!!! MrSparex 07/07/06 01:50:57 AM
PostSubject